ConductScience.org, home

Paper3114530

Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.

Nosoh Y and 7 others. Jpn J Surg, 1987. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice. Papers, record 3114530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3114530

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.
PubMed
Journal
Jpn J Surg
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.1
iCite
Revised in PubMed
2019-09-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nosoh YY
2Toge TT
3Niimi KK
4Nishiyama MM
5Hirabayashi NN
6Nakanishi KK
7Niimoto MM
8Hattori TT

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Breast NeoplasmsMajor topic
Gallbladder NeoplasmsMajor topic
Interferon Type IMajor topic
Interferon-gammaMajor topic
Mammary Neoplasms, ExperimentalMajor topic
Recombinant ProteinsMajor topic
Stomach NeoplasmsMajor topic
Animals
Cell Line
Drug Administration Schedule
Drug Therapy, Combination
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Transplantation

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16159047Does interferon cure cancer?Br Med J1980https://conductscience.org/library/papers/6159047PubMed
21203896Synergistic interaction of anticancer agents: a cellular perspective.Cancer Chemother Rep1975https://conductscience.org/library/papers/1203896PubMed
36175994Interferons: biochemical, cell growth inhibitory, and immunological effects.Prog Hematol1981https://conductscience.org/library/papers/6175994PubMed
46174218Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence.Cancer Res1982https://conductscience.org/library/papers/6174218PubMed
56195895Interferons with special emphasis on the immune system.Adv Immunol1983https://conductscience.org/library/papers/6195895PubMed
63932733In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon.Jpn J Surg1985https://conductscience.org/library/papers/3932733PubMed
7227796Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon.Infect Immun1979https://conductscience.org/library/papers/227796PubMed
86180825Synergism in the antitumor effects of type 1 and type II interferon in mice inoculated with leukemia L1210 cells.Cancer Lett1982https://conductscience.org/library/papers/6180825PubMed
94561966Mechanism of the antitumour effect of interferon in mice.Nature1972https://conductscience.org/library/papers/4561966PubMed
106172715Evidence that types I and II interferons have different receptors.Nature1981https://conductscience.org/library/papers/6172715PubMed
116433798[Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice].Gan To Kagaku Ryoho1984https://conductscience.org/library/papers/6433798PubMed
125514991Antitumor effects of interferon preparations in mice.J Natl Cancer Inst1970https://conductscience.org/library/papers/5514991PubMed
136174742Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer.JAMA1982https://conductscience.org/library/papers/6174742PubMed
146329104[A cooperative phase I-II study of HLBI in patients with malignant tumors].Gan To Kagaku Ryoho1984https://conductscience.org/library/papers/6329104PubMed
156319748Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons.J Virol1984https://conductscience.org/library/papers/6319748PubMed

Download CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3114530

GET https://conductscience.org/api/papers/v1/3114530/authors